Mimicking foot-and-mouth disease virus antigens with synthetic peptides.

Rowlands Dj
Annali Sclavo. Collana monografica 1 ( 2) 147 -161

1
1984
IDENTIFICATION OF T-CELL EPITOPES FROM HUMAN RHINOVIRUS FOR USE IN SYNTHETIC PEPTIDE VACCINES

Mj Francis , Ro Campbell , Gz Hastings , Bm Chain
In: BROWN, F and CHANOCK, RM and GINSBURG, HS and LERNER, RA, (eds.) VACCINES 92 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS. (pp. 259 - 264). COLD SPRING HARBOR LABORATORY PRESS (1992)

1992
Analysis of the role of DAF in the uncoating of DAF-binding enteroviruses

I. Goodfellow , D. Rowlands , Y. Chaudrhry , T. Tuthill
Australian Virology Group Abstract and Delegate Information

2005
Mapping of the Internal Ribosome Entry Site at the 5′ End of the Hepatitis C Virus Genome

H. Kettinen , K. Grace , S. Grunert , B. Clarke
Viral Hepatitis and Liver Disease 125 -131

9
1994
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.

J. Tormo , D. Blaas , N.R. Parry , D. Rowlands
The EMBO Journal 13 ( 10) 2247 -2256

119
1994
The solution structure of the immunodominant and cell receptor binding regions of foot-and-mouth disease virus serotype A, variant A.

M. Pegna , H. Molinari , L. Zetta , W. A. Gibbons
Journal of Peptide Science 2 ( 2) 75 -90

3
1996
Encephalomyocarditis virus antibodies in sera from apparently normal pigs

D. Sangar , D. Rowlands , F. Brown
Veterinary Record 100 ( 12) 240 -241

25
1977
The molecular biology of the positive strand RNA viruses

B.W.J. Mahy , Mayo , D.J. Rowlands
Academic Press Inc.,Orlando, FL

39
1987
How can peptide vaccines work

D.J. Rowlands
Fems Microbiology Letters 100 479 -481

6
1992
New advances in animal and human virus vaccines

D.J. Rowlands
Advances in biotechnological processes (USA) 6 253

3
1986
Mapping of neutralization epitopes of human rhinovirus type 2 with monoclonal antibodies

S.A. Speller , S.M. Russell , D.V. Sangar , M.J. Francis
Cold Spring Harbor Laboratory Press 431 -436

2
1989
Physicochemical characterization of two serologically unrelated equine rhinoviruses.

J.F.E. Newman , D.J. Rowlands , F. Brown , D. Goodridge
Intervirology 8 ( 3) 145 -154

19
1977
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus.

A.R. Carroll , D.J. Rowlands , B.E. Clarke
Nucleic Acids Research 12 ( 5) 2461 -2472

174
1984
Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus

B.E. Clarke , A.R. Carroll , D.J. Rowlands , B.H. Nicholson
FEBS Letters 157 ( 2) 261 -264

21
1983
THE CHEMICAL NATURE OF ANTIVIRAL SEROTYPE SPECIFICITY

T.M. Shinnick , J.G. Sutcliffe , J.L. Gerin , R.H. Purcell
Affinity Chromatography and Biological Recognition 343 -353

1983
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus.

B.E. Clarke , A.L. Brown , K.M. Currey , S.E. Newton
Nucleic Acids Research 15 ( 17) 7067 -7079

123
1987
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs

D.V. Sangar , S.E. Newton , D.J. Rowlands , B.E. Clarke
Nucleic Acids Research 15 ( 8) 3305 -3315

106
1987
Foot and Mouth Disease Viruses

D.J. Rowlands
Encyclopedia of Virology (Third Edition) 265 -274

3
2008
64
1991